Literature DB >> 24923595

Risk factors for perihilar cholangiocarcinoma: a hospital-based case-control study.

Ban Seok Lee1, Byung Hyo Cha, Eun-Cheol Park, Jaehoon Roh.   

Abstract

BACKGROUND & AIMS: Perihilar cholangiocarcinoma (pCCA) is the most common form of bile duct cancer, arising from cholangiocytes at the confluence of hepatic ducts. Given the diversity of cholangiocarcinoma (CCA) aetiology according to the location, and the scarcity of studies on the aetiology of pCCA, we aimed to identify the risk factors for pCCA.
METHODS: A total of 81 patients diagnosed with pCCA between July 2007 and December 2013, and 162 controls matched 2:1 for age, sex and date of diagnosis were included in this hospital-based case-control study. Potential risk factors were retrospectively investigated through clinical records, and the associations with pCCA were studied by calculating the odds ratios (ORs) using conditional logistic regression analysis.
RESULTS: In the univariate model, the prevalence of choledocholithiasis (OR: 14.00, P = 0.014), hepatolithiasis (OR: 12.00, P = 0.021) and diabetes mellitus (DM) (OR: 2.74, P = 0.005) was higher in pCCA patients than in controls. Heavy smoking and cirrhosis were marginally significant risk factors for pCCA (P < 0.1). Multivariate analysis revealed an association between pCCA and hepatolithiasis, choledocholithiasis, DM, and heavy smoking, each, with adjusted ORs of 16.47, 9.39, 3.36 and 2.52 respectively. DM, heavy smoking, hepatolithiasis and choledocholithiasis accounted for about 22.5%, 17.1%, 8.5% and 4.8% of pCCA risk respectively (population attributable risk percentage).
CONCLUSION: Our data showed that DM, heavy smoking, choledocholithiasis and hepatolithiasis were risk factors for pCCA development, implying that pCCA may share some aetiological factors with intrahepatic CCA although it has been classified as extrahepatic CCA.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  choledocholithiasis; diabetes mellitus; hepatolithiasis; perihilar cholangiocarcinoma; risk factor

Mesh:

Year:  2014        PMID: 24923595     DOI: 10.1111/liv.12618

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

1.  Predictive and prognostic molecular markers for cholangiocarcinoma in Han Chinese population.

Authors:  Lingqin Meng; Zhong Tian; Yong Wang; Yuan Liu; Jingang Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  A nomogram prediction of postoperative surgical site infections in patients with perihilar cholangiocarcinoma.

Authors:  Long Li; Jie Ding; Jun Han; Hong Wu
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

3.  Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis.

Authors:  Shou-Sheng Liu; Xue-Feng Ma; Jie Zhao; Shui-Xian Du; Jie Zhang; Meng-Zhen Dong; Yong-Ning Xin
Journal:  Lipids Health Dis       Date:  2020-05-31       Impact factor: 3.876

4.  Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge.

Authors:  Xiaoqi Zhou; Jifei Wang; Mimi Tang; Mengqi Huang; Ling Xu; Zhenpeng Peng; Zi-Ping Li; Shi-Ting Feng
Journal:  BMC Cancer       Date:  2020-01-22       Impact factor: 4.430

Review 5.  Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease.

Authors:  Huapeng Lin; Xinrong Zhang; Guanlin Li; Grace Lai-Hung Wong; Vincent Wai-Sun Wong
Journal:  J Clin Transl Hepatol       Date:  2021-08-30

6.  Age, gender, geographic and clinical differences for gallstones in China: a nationwide study.

Authors:  Yang Song; Yuan Ma; Fu-Cun Xie; Cheng Jin; Xiao-Bo Yang; Xu Yang; Jun-Yu Long; Dong-Xu Wang; Xin-Ting Sang; Li-Ming Li; Hai-Tao Zhao; Yi Ning
Journal:  Ann Transl Med       Date:  2022-07

7.  Associations between ultrasound screening findings and cholangiocarcinoma diagnosis in an at-risk population.

Authors:  Kavin Thinkhamrop; Narong Khuntikeo; Nittaya Chamadol; Apiporn T Suwannatrai; Surachai Phimha; Matthew Kelly
Journal:  Sci Rep       Date:  2022-08-06       Impact factor: 4.996

Review 8.  Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  Nicha Wongjarupong; Buravej Assavapongpaiboon; Paweena Susantitaphong; Wisit Cheungpasitporn; Sombat Treeprasertsuk; Rungsun Rerknimitr; Roongruedee Chaiteerakij
Journal:  BMC Gastroenterol       Date:  2017-12-08       Impact factor: 3.067

9.  Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  Yuenan Huang; Liuping You; Weimin Xie; Li Ning; Jinghe Lang
Journal:  Oncotarget       Date:  2017-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.